MAINE MEDICAL CENTER
- Type
- Teaching hospital
- Where
- Portland, ME
- Medicare CCN
- 200009
- Received
- $1,843,333 in 250 records, 2019 ($294,992 general, $1,548,341 research)
- Source
- CMS Open Payments search ↗
On this site
- Nonprofit contractor: Maine Medical Center Fuzzy (name and state)
- Lobbying client: MAINE MEDICAL CENTER Fuzzy (name and state)
- Patent assignee: Maine Medical Center Fuzzy (name and state)
- Trademark owner: Maine Medical Center Fuzzy (name and state)
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2019 | General payment | 81 | $294,992 |
| 2019 | Research payment | 169 | $1,548,341 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 169 | $1,548,341 |
| Grant | 6 | $268,502 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 16 | $7,948 |
| Gift | 36 | $7,560 |
| Charitable Contribution | 3 | $4,648 |
| Education | 10 | $3,239 |
| Space rental or facility fees (teaching hospital only) | 1 | $2,000 |
| Royalty or License | 9 | $1,093 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2019-12-31 | Monteris Medical Corporation | $4,600 | Grant | In-kind items and services | Neuroblate Device, Neuroblate | 2019 | |
| 2019-12-31 | Siemens Medical Solutions USA, Inc. | $353 | Charitable Contribution | In-kind items and services | 2019 | ||
| 2019-12-31 | Siemens Medical Solutions USA, Inc. | $295 | Charitable Contribution | In-kind items and services | 2019 | ||
| 2019-12-24 | Amgen Inc. | $1,484 | Research payment | Cash or cash equivalent | Repatha Biological, Cardiology | FOURIER OLE (Ph 4) | 2019 |
| 2019-12-20 | Genentech, Inc. | $8,742 | Research payment | Cash or cash equivalent | Avastin Biological, BioOncology | A PHASE III MULTICENTER RANDOMIZED PLACEBO CONTROLLED STUDY OF ATEZOLIZUMAB VERSUS PLACEBO IN COM | 2019 |
| 2019-12-20 | ABBVIE INC. | $1,457 | Research payment | Cash or cash equivalent | Humira Biological, Immunology | P11-292 | 2019 |
| 2019-12-12 | CSL Behring | $3,132 | Research payment | Cash or cash equivalent | Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II | 2019 | |
| 2019-12-09 | Genentech, Inc. | $25,662 | Research payment | Cash or cash equivalent | OCREVUS Biological, Immunology | ENSEMBLE | 2019 |
| 2019-12-09 | Genentech, Inc. | $4,540 | Research payment | Cash or cash equivalent | OCREVUS Biological, Immunology | ENSEMBLE | 2019 |
| 2019-12-09 | Clovis Oncology, Inc. | $3,533 | Research payment | Cash or cash equivalent | Rubraca Drug, ONCOLOGY | A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Fro | 2019 |
| 2019-12-06 | Abbott Laboratories | $2,400 | Research payment | Cash or cash equivalent | ABSORB Device, Vascular | A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects | 2019 |
| 2019-12-05 | LivaNova USA, Inc. | $6,478 | Research payment | Cash or cash equivalent | Perceval Device, Cardiology/Vascular Diseases | Sure-AVR Study | 2019 |
| 2019-12-05 | CSL Behring | $3,318 | Research payment | Cash or cash equivalent | Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II | 2019 | |
| 2019-12-05 | CSL Behring | $350 | Research payment | Cash or cash equivalent | Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II | 2019 | |
| 2019-12-03 | Kowa Research Institute, Inc. | $9,009 | Research payment | Cash or cash equivalent | Drug | K-877-302 | 2019 |
| 2019-11-27 | ABBVIE INC. | $10,500 | Research payment | Cash or cash equivalent | Humira Biological, Immunology | P11-292 | 2019 |
| 2019-11-25 | Janssen Research & Development, LLC | $14,311 | Research payment | Cash or cash equivalent | REMICADE Biological, Immunology | A multi center prospective long term observational registry of pediatric patients with IBS | 2019 |
| 2019-11-25 | Genentech, Inc. | $1,737 | Research payment | Cash or cash equivalent | Non-Covered Product Drug, None | PRODROMAL TO MILD AD | 2019 |
| 2019-11-19 | Boehringer Ingelheim Pharmaceuticals, Inc. | $7,475 | Research payment | Cash or cash equivalent | PRADAXA Drug, CARDIOVASCULAR | GLORIA AF Registry Phase II III Core | 2019 |
| 2019-11-18 | Genentech, Inc. | $30,707 | Research payment | Cash or cash equivalent | OCREVUS Biological, Immunology | ENSEMBLE | 2019 |
| 2019-11-18 | GENZYME CORPORATION | $650 | Research payment | Cash or cash equivalent | FABRY-DISEASE Drug | Fabry LSD Data Registry | 2019 |
| 2019-11-18 | GENZYME CORPORATION | $225 | Research payment | Cash or cash equivalent | GAUCHER-DISEASE Drug | Gaucher LSD Data Registry | 2019 |
| 2019-11-15 | Artivion, Inc. | $670 | Research payment | Cash or cash equivalent | On-X Device, Cardiology and Vascular Diseases | ON-X Prosthetic Heart Valve-Anatomic Suture Ring Postmarket Registry | 2019 |
| 2019-11-14 | Clovis Oncology, Inc. | $6,890 | Research payment | Cash or cash equivalent | Rubraca Drug, ONCOLOGY | A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Fro | 2019 |
| 2019-11-12 | Genentech, Inc. | $8,126 | Research payment | Cash or cash equivalent | Avastin Biological, BioOncology | A PHASE III MULTICENTER RANDOMIZED PLACEBO CONTROLLED STUDY OF ATEZOLIZUMAB VERSUS PLACEBO IN COM | 2019 |
| 2019-11-07 | CSL Behring | $3,932 | Research payment | Cash or cash equivalent | Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II | 2019 | |
| 2019-11-07 | CSL Behring | $100 | Research payment | Cash or cash equivalent | Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II | 2019 | |
| 2019-10-30 | Edwards Lifesciences Corporation | $1,790 | Research payment | Cash or cash equivalent | Early-TAVR Trial 2016-07 | 2019 | |
| 2019-10-30 | Cardiovascular Systems Inc. | $634 | Research payment | Cash or cash equivalent | Coronary Orbital Atherectomy System Device, Atherectomy Device | ECLIPSE | 2019 |
| 2019-10-30 | Cardiovascular Systems Inc. | $75 | Research payment | Cash or cash equivalent | Coronary Orbital Atherectomy System Device, Atherectomy Device | ECLIPSE | 2019 |
| 2019-10-28 | Amgen Inc. | $136,550 | Research payment | In-kind items and services | Repatha Biological, Cardiology | A randomized trial of evolocumab on saphenous vein graft patency following coronary artery bypass surgery (NEWTON-CABG) | 2019 |
| 2019-10-25 | Kowa Research Institute, Inc. | $1,287 | Research payment | Cash or cash equivalent | Drug | K-877-302 | 2019 |
| 2019-10-24 | Genentech, Inc. | $2,063 | Research payment | Cash or cash equivalent | Non-Covered Product Drug, None | PRODROMAL TO MILD AD | 2019 |
| 2019-10-24 | EMD Serono, Inc. | $1,542 | Research payment | Cash or cash equivalent | Bavencio Biological, Oncology | MS201943-0029 | 2019 |
| 2019-10-21 | Genentech, Inc. | $5,016 | Research payment | Cash or cash equivalent | Avastin Biological, BioOncology | A PHASE III MULTICENTER RANDOMIZED PLACEBO CONTROLLED STUDY OF ATEZOLIZUMAB VERSUS PLACEBO IN COM | 2019 |
| 2019-10-21 | ABBVIE INC. | $2,280 | Research payment | Cash or cash equivalent | M13-813 | 2019 | |
| 2019-10-15 | Clovis Oncology, Inc. | $1,156 | Research payment | Cash or cash equivalent | Rubraca Drug, ONCOLOGY | A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Fro | 2019 |
| 2019-10-14 | Artivion, Inc. | $670 | Research payment | Cash or cash equivalent | On-X Device, Cardiology and Vascular Diseases | ON-X Prosthetic Heart Valve-Anatomic Suture Ring Postmarket Registry | 2019 |
| 2019-10-10 | SANOFI PASTEUR INC. | $18,055 | Research payment | Cash or cash equivalent | YELLOW FEVER Drug | STA00011 Stamaril Yellow Fever | 2019 |
| 2019-10-09 | Stryker Corporation | $1,739 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2019 | |
| 2019-10-09 | Stryker Corporation | $659 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2019 | |
| 2019-10-09 | Olympus America Inc. | $330 | Gift | In-kind items and services | 2019 | ||
| 2019-10-09 | Stryker Corporation | $92 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2019 | |
| 2019-10-09 | Stryker Corporation | $19 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2019 | |
| 2019-10-08 | TESARO, Inc. | $11,757 | Research payment | Cash or cash equivalent | A PHASE 1 DOSE ESCALATION AND COHORT EXPANSION STUDY OF TSR-042, AN ANTI-PD-1 MONOCLONAL ANTIBODY, IN PATIENTS WITH ADVA | 2019 | |
| 2019-10-04 | Genentech, Inc. | $18,921 | Research payment | Cash or cash equivalent | Avastin Biological, BioOncology | A PHASE III MULTICENTER RANDOMIZED PLACEBO CONTROLLED STUDY OF ATEZOLIZUMAB VERSUS PLACEBO IN COM | 2019 |
| 2019-10-04 | Genentech, Inc. | $7,210 | Research payment | Cash or cash equivalent | Avastin Biological, BioOncology | A PHASE III MULTICENTER RANDOMIZED PLACEBO CONTROLLED STUDY OF ATEZOLIZUMAB VERSUS PLACEBO IN COM | 2019 |
| 2019-10-02 | Genentech, Inc. | $24,078 | Research payment | Cash or cash equivalent | Non-Covered Product Drug, None | PRODROMAL TO MILD AD | 2019 |
| 2019-10-02 | Cardiovascular Systems Inc. | $512 | Research payment | Cash or cash equivalent | Coronary Orbital Atherectomy System Device, Atherectomy Device | ECLIPSE | 2019 |
| 2019-10-01 | Kowa Research Institute, Inc. | $4,212 | Research payment | Cash or cash equivalent | Drug | K-877-302 | 2019 |
| 2019-09-28 | FUJIFILM SonoSite, Inc. | $777 | Education | In-kind items and services | Edge/Edge II Ultrasound System Device, Medical Device | 2019 | |
| 2019-09-25 | ABBVIE INC. | $613 | Research payment | Cash or cash equivalent | Humira Biological, Immunology | P11-292 | 2019 |
| 2019-09-16 | Boston Scientific Corporation | $2,704 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | ASAP TOO | 2019 |
| 2019-09-09 | Clovis Oncology, Inc. | $2,053 | Research payment | Cash or cash equivalent | Rubraca Drug, ONCOLOGY | A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Fro | 2019 |
| 2019-09-09 | Abbott Laboratories | $1,462 | Research payment | Cash or cash equivalent | ABSORB Device, Vascular | A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects | 2019 |
| 2019-09-05 | Genentech, Inc. | $4,118 | Research payment | Cash or cash equivalent | Non-Covered Product Drug, None | PRODROMAL TO MILD AD | 2019 |
| 2019-08-23 | Janssen Research & Development, LLC | $14,981 | Research payment | Cash or cash equivalent | REMICADE Biological, Immunology | A multi center prospective long term observational registry of pediatric patients with IBS | 2019 |
| 2019-08-21 | Genentech, Inc. | $27,268 | Research payment | Cash or cash equivalent | Avastin Biological, BioOncology | A PHASE III MULTICENTER RANDOMIZED PLACEBO CONTROLLED STUDY OF ATEZOLIZUMAB VERSUS PLACEBO IN COM | 2019 |
| 2019-08-21 | Genentech, Inc. | $1,664 | Research payment | Cash or cash equivalent | Non-Covered Product Drug, None | PRODROMAL TO MILD AD | 2019 |
| 2019-08-19 | Genentech, Inc. | $18,330 | Research payment | Cash or cash equivalent | OCREVUS Biological, Immunology | ENSEMBLE | 2019 |
| 2019-08-19 | Boston Scientific Corporation | $2,226 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | ASAP TOO | 2019 |
| 2019-08-12 | Genentech, Inc. | $12,823 | Research payment | Cash or cash equivalent | OCREVUS Biological, Immunology | ENSEMBLE | 2019 |
| 2019-08-02 | Amgen Inc. | $28,803 | Research payment | In-kind items and services | Repatha Biological, Cardiology | FOURIER OLE (Ph 4) | 2019 |
| 2019-07-29 | Genentech, Inc. | $18,244 | Research payment | Cash or cash equivalent | OCREVUS Biological, Immunology | ENSEMBLE | 2019 |
| 2019-07-25 | Cardiovascular Systems Inc. | $117 | Research payment | Cash or cash equivalent | Coronary Orbital Atherectomy System Device, Atherectomy Device | ECLIPSE | 2019 |
| 2019-07-24 | Genentech, Inc. | $4,453 | Research payment | Cash or cash equivalent | Non-Covered Product Drug, None | PRODROMAL TO MILD AD | 2019 |
| 2019-07-22 | AKEBIA THERAPEUTICS INC | $921 | Research payment | Cash or cash equivalent | AKB-6548-CI-0015 | 2019 | |
| 2019-07-18 | Kowa Research Institute, Inc. | $5,031 | Research payment | Cash or cash equivalent | Drug | K-877-302 | 2019 |
| 2019-07-16 | Stryker Corporation | $1,243 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2019 | |
| 2019-07-16 | Stryker Corporation | $516 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2019 | |
| 2019-07-16 | Stryker Corporation | $86 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2019 | |
| 2019-07-16 | Stryker Corporation | $40 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2019 | |
| 2019-07-15 | Genentech, Inc. | $7,332 | Research payment | Cash or cash equivalent | OCREVUS Biological, Immunology | ENSEMBLE | 2019 |
| 2019-07-15 | Clovis Oncology, Inc. | $5,407 | Research payment | Cash or cash equivalent | Rubraca Drug, ONCOLOGY | A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Fro | 2019 |
| 2019-07-15 | Medline Industries LP | $4,000 | Charitable Contribution | Cash or cash equivalent | 2019 | ||
| 2019-07-11 | Genentech, Inc. | $27,705 | Research payment | Cash or cash equivalent | Avastin Biological, BioOncology | A PHASE III MULTICENTER RANDOMIZED PLACEBO CONTROLLED STUDY OF ATEZOLIZUMAB VERSUS PLACEBO IN COM | 2019 |
| 2019-07-11 | LivaNova USA, Inc. | $8,643 | Research payment | Cash or cash equivalent | Perceval Device, Cardiology/Vascular Diseases | Believe APR002 Study | 2019 |
| 2019-07-10 | Amgen Inc. | $188 | Research payment | In-kind items and services | GALACTIC-HF | 2019 | |
| 2019-07-09 | AKEBIA THERAPEUTICS INC | $252 | Research payment | Cash or cash equivalent | AKB-6548-CI-0014 | 2019 | |
| 2019-07-08 | Genentech, Inc. | $1,369 | Research payment | Cash or cash equivalent | Non-Covered Product Drug, None | PRODROMAL TO MILD AD | 2019 |
| 2019-07-02 | Bayer Healthcare Pharmaceuticals Inc. | $2,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Adempas Drug, Cardio-pulmonary | 2019 | |
| 2019-07-02 | Amgen Inc. | $1,697 | Research payment | In-kind items and services | GALACTIC-HF | 2019 | |
| 2019-06-28 | ABBVIE INC. | $1,380 | Research payment | Cash or cash equivalent | Humira Biological, Immunology | P11-292 | 2019 |
| 2019-06-27 | Allergan, Inc. | $1,150 | Research payment | Cash or cash equivalent | ZENPEP Drug, CYSTIC FIBROSIS | LONG-TERM STUDY IN US CYSTIC FIBROSIS PATIENTS RECEIVING DIGESTIVE ENZYME SUPPLEMENTS TO ASSESS ANY NARROWING OF THE LAR | 2019 |
| 2019-06-27 | ABBVIE INC. | $540 | Research payment | Cash or cash equivalent | Creon Drug, Endocrinology | P12-792 | 2019 |
| 2019-06-27 | VIVUS LLC | $181 | Research payment | Cash or cash equivalent | PANCREAZE Drug, CYSTIC FIBROSIS | Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large I | 2019 |
| 2019-06-26 | KARL STORZ Endoscopy-America | $90 | Gift | In-kind items and services | TELESCOPE,HOPKINS II, 0, ENLARGED VIEW, Device, LAPAROSCOPY | 2019 | |
| 2019-06-26 | KARL STORZ Endoscopy-America | $30 | Gift | In-kind items and services | TELESCOPE,HOPKINS II,AUTOCLAV, Device, UROLOGY | 2019 | |
| 2019-06-26 | KARL STORZ Endoscopy-America | $30 | Gift | In-kind items and services | LIGHT CABLE, 3.5MM X 300CM. LGTH 9.8 FT Device, VIDEOIMAGING | 2019 | |
| 2019-06-21 | Pharmacyclics LLC, an AbbVie Company | $350 | Research payment | Cash or cash equivalent | Ibrutinib Drug, Oncology | PCYC-1134M-CA | 2019 |
| 2019-06-21 | Pharmacyclics LLC, an AbbVie Company | $350 | Research payment | Cash or cash equivalent | Ibrutinib Drug, Oncology | PCYC-1134M-CA | 2019 |
| 2019-06-21 | Pharmacyclics LLC, an AbbVie Company | $190 | Research payment | Cash or cash equivalent | Ibrutinib Drug, Oncology | PCYC-1134M-CA | 2019 |
| 2019-06-21 | Pharmacyclics LLC, an AbbVie Company | $190 | Research payment | Cash or cash equivalent | Ibrutinib Drug, Oncology | PCYC-1134M-CA | 2019 |
| 2019-06-21 | Pharmacyclics LLC, an AbbVie Company | $190 | Research payment | Cash or cash equivalent | Ibrutinib Drug, Oncology | PCYC-1134M-CA | 2019 |
| 2019-06-17 | Boston Scientific Corporation | $716 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | ASAP TOO | 2019 |
| 2019-06-12 | KARL STORZ Endoscopy-America | $300 | Gift | In-kind items and services | TELESCOPE,HOPKINS II,AUTOCLAV, Device, UROLOGY | 2019 | |
| 2019-06-12 | KARL STORZ Endoscopy-America | $270 | Gift | In-kind items and services | TELESCOPE,HOPKINS II, 0, ENLARGED VIEW, Device, LAPAROSCOPY | 2019 | |
| 2019-06-12 | KARL STORZ Endoscopy-America | $60 | Gift | In-kind items and services | TELESCOPE, HOPKINS II, 0', 4MM DIAMETER Device, ENT | 2019 | |
| 2019-06-12 | KARL STORZ Endoscopy-America | $30 | Gift | In-kind items and services | SCISSORS,HORIZ CUT,RIGHT,SNGL Device, GYNECOLOGY | 2019 | |
| 2019-06-07 | Abbott Laboratories | $662 | Research payment | Cash or cash equivalent | ABSORB Device, Vascular | A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects | 2019 |
| 2019-06-06 | Cardiovascular Systems Inc. | $37 | Research payment | Cash or cash equivalent | Coronary Orbital Atherectomy System Device, Atherectomy Device | ECLIPSE | 2019 |
| 2019-06-03 | Boston Scientific Corporation | $3,372 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | ASAP TOO | 2019 |
| 2019-05-27 | Amgen Inc. | $231 | Research payment | In-kind items and services | GALACTIC-HF | 2019 | |
| 2019-05-22 | Kowa Research Institute, Inc. | $6,201 | Research payment | Cash or cash equivalent | Drug | K-877-302 | 2019 |
| 2019-05-20 | Pharmacyclics LLC, an AbbVie Company | $190 | Research payment | Cash or cash equivalent | Ibrutinib Drug, Oncology | PCYC-1134M-CA | 2019 |
| 2019-05-20 | Pharmacyclics LLC, an AbbVie Company | $190 | Research payment | Cash or cash equivalent | Ibrutinib Drug, Oncology | PCYC-1134M-CA | 2019 |
| 2019-05-20 | Pharmacyclics LLC, an AbbVie Company | $190 | Research payment | Cash or cash equivalent | Ibrutinib Drug, Oncology | PCYC-1134M-CA | 2019 |
| 2019-05-16 | TESARO, Inc. | $2,296 | Research payment | Cash or cash equivalent | A PHASE 1 DOSE ESCALATION AND COHORT EXPANSION STUDY OF TSR-042, AN ANTI-PD-1 MONOCLONAL ANTIBODY, IN PATIENTS WITH ADVA | 2019 | |
| 2019-05-16 | TESARO, Inc. | $2,165 | Research payment | Cash or cash equivalent | A PHASE 1 DOSE ESCALATION AND COHORT EXPANSION STUDY OF TSR-042, AN ANTI-PD-1 MONOCLONAL ANTIBODY, IN PATIENTS WITH ADVA | 2019 | |
| 2019-05-16 | TESARO, Inc. | $1,950 | Research payment | Cash or cash equivalent | A PHASE 1 DOSE ESCALATION AND COHORT EXPANSION STUDY OF TSR-042, AN ANTI-PD-1 MONOCLONAL ANTIBODY, IN PATIENTS WITH ADVA | 2019 | |
| 2019-05-15 | Edwards Lifesciences Corporation | $5,000 | Research payment | Cash or cash equivalent | Edwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart Valves | Early-TAVR Trial 2016-07 | 2019 |
| 2019-05-15 | FUJIFILM SonoSite, Inc. | $486 | Education | In-kind items and services | Edge/Edge II Ultrasound System Device, Medical Device | 2019 | |
| 2019-05-13 | Genentech, Inc. | $75,956 | Research payment | Cash or cash equivalent | Avastin Biological, BioOncology | A PHASE III MULTICENTER RANDOMIZED PLACEBO CONTROLLED STUDY OF ATEZOLIZUMAB VERSUS PLACEBO IN COM | 2019 |
| 2019-05-13 | Eli Lilly and Company | $62,127 | Research payment | Cash or cash equivalent | EFFECT OF LY3154207 ON COGNITION IN MILD TO MODERATE PARKINSONS DISEASE DEMENTIA PDD - THE PRESENCE STUDY | 2019 | |
| 2019-05-13 | Genentech, Inc. | $42,169 | Research payment | Cash or cash equivalent | OCREVUS Biological, Immunology | ENSEMBLE | 2019 |
| 2019-05-10 | Edwards Lifesciences Corporation | $6,641 | Research payment | Cash or cash equivalent | Early-TAVR Trial 2016-07 | 2019 | |
| 2019-05-09 | Janssen Research & Development, LLC | $18,413 | Research payment | Cash or cash equivalent | REMICADE Biological, Immunology | A multi center prospective long term observational registry of pediatric patients with IBS | 2019 |
| 2019-05-03 | Genentech, Inc. | $5,514 | Research payment | Cash or cash equivalent | Non-Covered Product Drug, None | PRODROMAL TO MILD AD | 2019 |
| 2019-05-03 | Masimo Corporation | $428 | Education | In-kind items and services | rainbow Acoustic Monitoring Device, Devices | 2019 | |
| 2019-04-30 | Artivion, Inc. | $1,303 | Research payment | Cash or cash equivalent | On-X Device, Cardiology and Vascular Diseases | ON-X Prosthetic Heart Valve-Anatomic Suture Ring Postmarket Registry | 2019 |
| 2019-04-27 | Masimo Corporation | $228 | Education | In-kind items and services | rainbow Acoustic Monitoring Device, Devices | 2019 | |
| 2019-04-26 | Edwards Lifesciences Corporation | $15,000 | Grant | Cash or cash equivalent | 2019 | ||
| 2019-04-26 | ABBVIE INC. | $690 | Research payment | Cash or cash equivalent | Humira Biological, Immunology | P11-292 | 2019 |
| 2019-04-25 | Clovis Oncology, Inc. | $27,650 | Research payment | Cash or cash equivalent | Rubraca Drug, ONCOLOGY | A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Fro | 2019 |
| 2019-04-25 | Cardiovascular Systems Inc. | $4,728 | Research payment | Cash or cash equivalent | Coronary Orbital Atherectomy System Device, Atherectomy Device | ECLIPSE | 2019 |
| 2019-04-25 | E.R. Squibb & Sons, L.L.C. | $2,325 | Research payment | Cash or cash equivalent | NULOJIX Biological, Immunology | Evaluating Nulojix Long-Term Safety in Transplant | 2019 |
| 2019-04-25 | Masimo Corporation | $140 | Education | In-kind items and services | rainbow Acoustic Monitoring Device, Devices | 2019 | |
| 2019-04-24 | KARL STORZ Endoscopy-America | $600 | Gift | In-kind items and services | ASM,HEAD,IMAGE1 S,H3-Z, CE Device, VIDEOIMAGING | 2019 | |
| 2019-04-24 | Pharmacyclics LLC, an AbbVie Company | $190 | Research payment | Cash or cash equivalent | Ibrutinib Drug, Oncology | PCYC-1134M-CA | 2019 |
| 2019-04-24 | Pharmacyclics LLC, an AbbVie Company | $190 | Research payment | Cash or cash equivalent | Ibrutinib Drug, Oncology | PCYC-1134M-CA | 2019 |
| 2019-04-24 | Pharmacyclics LLC, an AbbVie Company | $190 | Research payment | Cash or cash equivalent | Ibrutinib Drug, Oncology | PCYC-1134M-CA | 2019 |
| 2019-04-24 | KARL STORZ Endoscopy-America | $150 | Gift | In-kind items and services | TELESCOPE,HOPKINS II, 0, ENLARGED VIEW, Device, LAPAROSCOPY | 2019 | |
| 2019-04-23 | LivaNova USA, Inc. | $1,748 | Research payment | Cash or cash equivalent | Perceval Device, Cardiology/Vascular Diseases | Believe APR002 Study | 2019 |
| 2019-04-22 | Boston Scientific Corporation | $2,726 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | ASAP TOO | 2019 |
| 2019-04-17 | LivaNova USA, Inc. | $100,000 | Grant | Cash or cash equivalent | Perceval Device, Cardiology/Vascular Diseases | 2019 | |
| 2019-04-16 | EMD Serono, Inc. | $9,000 | Research payment | Cash or cash equivalent | Bavencio Biological, Oncology | MS 201943-0029 | 2019 |
| 2019-04-16 | EMD Serono, Inc. | $1,250 | Research payment | Cash or cash equivalent | Bavencio Biological, Oncology | MS 201943-0029 | 2019 |
| 2019-04-15 | Janssen Research & Development, LLC | $13,460 | Research payment | Cash or cash equivalent | A Phase 4, Multicenter, Open-label Study of Serum Infliximab Concentrations and Efficacy and Safety of Dose Escalation i | 2019 | |
| 2019-04-15 | VERTEX PHARMACEUTICALS INCORPORATED | $4,667 | Research payment | Cash or cash equivalent | ORKAMBI Drug, CYSTIC FIBROSIS | A Post-approval Observational Study to Evaluate the Long-term Effectiveness and Safety of Orkambi in US Patients Who Com | 2019 |
| 2019-04-15 | Janssen Research & Development, LLC | $1,582 | Research payment | Cash or cash equivalent | A Phase 4, Multicenter, Open-label Study of Serum Infliximab Concentrations and Efficacy and Safety of Dose Escalation i | 2019 | |
| 2019-04-12 | Stryker Corporation | $1,081 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2019 | |
| 2019-04-12 | Stryker Corporation | $379 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2019 | |
| 2019-04-12 | Stryker Corporation | $155 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2019 | |
| 2019-04-12 | Stryker Corporation | $31 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | 2019 | |
| 2019-04-11 | Janssen Research & Development, LLC | $7,450 | Research payment | Cash or cash equivalent | YONDELIS Drug, Oncology | A Randomized, Open-Label Study Comparing the Combination of YONDELIS and DOXIL/CAELYX With DOXIL/CAELYX Monotherapy for | 2019 |
| 2019-04-09 | Bard Peripheral Vascular, Inc. | $1,296 | Research payment | Cash or cash equivalent | LUTONIX Device, PERIPHERAL VASCULAR | SAFE-DCB REGISTRY BPV14006 | 2019 |
| 2019-04-09 | Helsinn Healthcare SA | $600 | Research payment | Cash or cash equivalent | NETUPITANT Drug, ONCOLOGY | A multicenter, multinational, randomized, double-blind, pharmacokinetic and pharmacodynamic PKPD dose-finding study of o | 2019 |
| 2019-04-04 | Cardiovascular Systems Inc. | $62 | Research payment | Cash or cash equivalent | Coronary Orbital Atherectomy System Device, Atherectomy Device | ECLIPSE | 2019 |
| 2019-04-03 | Artivion, Inc. | $1,303 | Research payment | Cash or cash equivalent | On-X Device, Cardiology and Vascular Diseases | ON-X Prosthetic Heart Valve-Anatomic Suture Ring Postmarket Registry | 2019 |
| 2019-04-03 | KARL STORZ Endoscopy-America | $210 | Gift | In-kind items and services | ASM,HEAD,IMAGE1 S,H3-Z, CE Device, VIDEOIMAGING | 2019 | |
| 2019-04-03 | KARL STORZ Endoscopy-America | $180 | Gift | In-kind items and services | TELESCOPE,HOPKINS II, 0, ENLARGED VIEW, Device, LAPAROSCOPY | 2019 | |
| 2019-04-03 | KARL STORZ Endoscopy-America | $150 | Gift | In-kind items and services | TELESCOPE, HOPKINS II, 0', 4MM DIAMETER Device, ENT | 2019 | |
| 2019-04-03 | KARL STORZ Endoscopy-America | $150 | Gift | In-kind items and services | TELESCOPE,HOPKINS II,AUTOCLAV, Device, UROLOGY | 2019 | |
| 2019-04-02 | FUJIFILM SonoSite, Inc. | $49 | Education | In-kind items and services | Edge/Edge II Ultrasound System Device, Medical Device | 2019 | |
| 2019-04-01 | Amgen Inc. | $51,206 | Research payment | In-kind items and services | Repatha Biological, Cardiology | FOURIER OLE (Ph 4) | 2019 |
| 2019-04-01 | Bard Peripheral Vascular, Inc. | $19 | Education | In-kind items and services | WAVELINQ Device, PERIPHERAL VASCULAR | 2019 | |
| 2019-04-01 | Bard Peripheral Vascular, Inc. | $14 | Education | In-kind items and services | WAVELINQ Device, PERIPHERAL VASCULAR | 2019 | |
| 2019-03-27 | Daiichi Sankyo Inc. | $5,400 | Research payment | Cash or cash equivalent | Savaysa Drug, Thrombosis | ENVISAGE | 2019 |
| 2019-03-27 | Daiichi Sankyo Inc. | $2,135 | Research payment | Cash or cash equivalent | Savaysa Drug, Thrombosis | ENVISAGE | 2019 |
| 2019-03-27 | Daiichi Sankyo Inc. | $1,365 | Research payment | Cash or cash equivalent | Savaysa Drug, Thrombosis | ENVISAGE | 2019 |
| 2019-03-27 | Daiichi Sankyo Inc. | $1,365 | Research payment | Cash or cash equivalent | Savaysa Drug, Thrombosis | ENVISAGE | 2019 |
| 2019-03-27 | Amgen Inc. | $1,165 | Research payment | Cash or cash equivalent | GALACTIC-HF | 2019 | |
| 2019-03-27 | Daiichi Sankyo Inc. | $682 | Research payment | Cash or cash equivalent | Savaysa Drug, Thrombosis | ENVISAGE | 2019 |
| 2019-03-26 | Cook Incorporated | $2,370 | Grant | Cash or cash equivalent | 2019 | ||
| 2019-03-21 | KARL STORZ Endoscopy-America | $210 | Gift | In-kind items and services | ASM,HEAD,IMAGE1 S,H3-Z, CE Device, VIDEOIMAGING | 2019 | |
| 2019-03-20 | KARL STORZ Endoscopy-America | $510 | Gift | In-kind items and services | TELESCOPE,HOPKINS II,AUTOCLAV, Device, UROLOGY | 2019 | |
| 2019-03-20 | KARL STORZ Endoscopy-America | $90 | Gift | In-kind items and services | ASM,HEAD,IMAGE1 S,H3-Z, CE Device, VIDEOIMAGING | 2019 | |
| 2019-03-20 | KARL STORZ Endoscopy-America | $60 | Gift | In-kind items and services | TELESCOPE, HOPKINS II, 0', 4MM DIAMETER Device, ENT | 2019 | |
| 2019-03-20 | KARL STORZ Endoscopy-America | $60 | Gift | In-kind items and services | TELESCOPE,HOPKINS II, 0, ENLARGED VIEW, Device, LAPAROSCOPY | 2019 | |
| 2019-03-18 | Boston Scientific Corporation | $7,150 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | ASAP TOO | 2019 |
| 2019-03-13 | Abbott Laboratories | $4,182 | Research payment | Cash or cash equivalent | Absorb Device, Vascular | A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects | 2019 |
| 2019-03-12 | AstraZeneca Pharmaceuticals LP | $3,297 | Research payment | Cash or cash equivalent | FARXIGA Drug, Cardiovascular and Metabolism | Dapagliflozin Effect on Cardiovascular Events A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Eval | 2019 |
| 2019-03-08 | Genentech, Inc. | $7,030 | Research payment | Cash or cash equivalent | Non-Covered Product Drug, None | PRODROMAL TO MILD AD | 2019 |
| 2019-03-06 | H. Lundbeck A S | $7,822 | Research payment | Cash or cash equivalent | NORTHERA Drug, NEUROLOGY | Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension RESTORE | 2019 |
| 2019-03-06 | FUJIFILM SonoSite, Inc. | $732 | Education | In-kind items and services | Edge/Edge II Ultrasound System Device, Medical Device | 2019 | |
| 2019-03-06 | KARL STORZ Endoscopy-America | $330 | Gift | In-kind items and services | ASM,HEAD,IMAGE1 S,H3-Z, CE Device, VIDEOIMAGING | 2019 | |
| 2019-03-06 | KARL STORZ Endoscopy-America | $330 | Gift | In-kind items and services | CARRIER, FIBER OPTIC LIGHT, Device, ENT | 2019 | |
| 2019-03-06 | KARL STORZ Endoscopy-America | $300 | Gift | In-kind items and services | TELESCOPE,HOPKINS II, 0, ENLARGED VIEW, Device, LAPAROSCOPY | 2019 | |
| 2019-03-06 | KARL STORZ Endoscopy-America | $210 | Gift | In-kind items and services | IRRIGATION SHEATH, 5.0MM X 14CM, FOR USE Device, NEUROSURGERY | 2019 | |
| 2019-03-06 | KARL STORZ Endoscopy-America | $30 | Gift | In-kind items and services | TELESCOPE,HOPKINS II,AUTOCLAV, Device, UROLOGY | 2019 | |
| 2019-03-05 | Eisai Inc. | $4,236 | Research payment | Cash or cash equivalent | Belviq Drug, Nutrition and Weight Loss | A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Effect of Long-term Treatment With | 2019 |
| 2019-02-28 | Medtronic Vascular, Inc. | $7,842 | Research payment | Cash or cash equivalent | TYRX Device, Antibacterial Mesh | WRAP-IT | 2019 |
| 2019-02-22 | Janssen Research & Development, LLC | $12,708 | Research payment | Cash or cash equivalent | REMICADE Biological, Immunology | A multi center prospective long term observational registry of pediatric patients with IBS | 2019 |
| 2019-02-22 | ABBVIE INC. | $2,718 | Research payment | Cash or cash equivalent | Humira Biological, Immunology | P11-292 | 2019 |
| 2019-02-20 | ACADIA Pharmaceuticals Inc | $3,500 | Research payment | Cash or cash equivalent | NUPLAZID Drug, PARKINSONS DISEASE PSYCHOSIS | ACA 16-cAC-0001 | 2019 |
| 2019-02-20 | ACADIA Pharmaceuticals Inc | $3,500 | Research payment | Cash or cash equivalent | NUPLAZID Drug, PARKINSONS DISEASE PSYCHOSIS | ACA 16-cAC-0001 | 2019 |
| 2019-02-20 | KARL STORZ Endoscopy-America | $360 | Gift | In-kind items and services | TELESCOPE,HOPKINS II, 0, ENLARGED VIEW, Device, LAPAROSCOPY | 2019 | |
| 2019-02-20 | KARL STORZ Endoscopy-America | $300 | Gift | In-kind items and services | ASM,HEAD,IMAGE1 S,H3-Z, CE Device, VIDEOIMAGING | 2019 | |
| 2019-02-20 | KARL STORZ Endoscopy-America | $240 | Gift | In-kind items and services | HOPKINS II TELESCOPE, 0, 2.7MM X 18CM Device, ENT | 2019 | |
| 2019-02-20 | KARL STORZ Endoscopy-America | $90 | Gift | In-kind items and services | 7.5 FR. X 650 INTUBATION SCOPE Device, ANESTHESIOLOGY | 2019 | |
| 2019-02-20 | KARL STORZ Endoscopy-America | $90 | Gift | In-kind items and services | TELESCOPE,HOPKINS II,AUTOCLAV, Device, UROLOGY | 2019 | |
| 2019-02-20 | KARL STORZ Endoscopy-America | $30 | Gift | In-kind items and services | SCISSORS,HORIZ CUT,RIGHT,SNGL Device, GYNECOLOGY | 2019 | |
| 2019-02-19 | Clovis Oncology, Inc. | $13,815 | Research payment | Cash or cash equivalent | Rubraca Drug, ONCOLOGY | ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patie | 2019 |
| 2019-02-19 | Clovis Oncology, Inc. | $3,393 | Research payment | Cash or cash equivalent | Rubraca Drug, ONCOLOGY | ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patie | 2019 |
| 2019-02-19 | EMD Millipore Corporation | $233 | Royalty or License | Cash or cash equivalent | Device, DIAGNOSTIC TESTING | 2019 | |
| 2019-02-19 | EMD Millipore Corporation | $212 | Royalty or License | Cash or cash equivalent | Device, DIAGNOSTIC TESTING | 2019 | |
| 2019-02-19 | EMD Millipore Corporation | $145 | Royalty or License | Cash or cash equivalent | Device, DIAGNOSTIC TESTING | 2019 | |
| 2019-02-19 | EMD Millipore Corporation | $133 | Royalty or License | Cash or cash equivalent | Device, DIAGNOSTIC TESTING | 2019 | |
| 2019-02-19 | EMD Millipore Corporation | $104 | Royalty or License | Cash or cash equivalent | Device, DIAGNOSTIC TESTING | 2019 | |
| 2019-02-19 | EMD Millipore Corporation | $68 | Royalty or License | Cash or cash equivalent | Device, DIAGNOSTIC TESTING | 2019 |
The latest 200 records of 250.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Portland, ME, county Cumberland County, ME, state Maine; placed by its city name.
| Measure | Place (city or town) Portland, ME | County Cumberland County, ME | State Maine |
|---|---|---|---|
| Population B01003 | 68,854 | 308,827 | 1,387,817 |
| Population, 2020 census P1 | 68,408 | 303,069 | 1,362,359 |
| Median age B01002 | 37.8 | 42.2 | 44.8 |
| Under 18 B01001 | 15.4% | 18.0% | 18.1% |
| 65 and over B01001 | 16.9% | 20.4% | 22.4% |
| Households B11001 | 32,965 | 132,168 | 597,159 |
| Foreign born B05002 | 11.8% | 6.7% | 4.1% |
| Median household income B19013 | $79,540 | $95,677 | $74,733 |
| Median family income B19113 | $118,777 | $124,273 | $96,912 |
| Per capita income B19301 | $52,781 | $55,739 | $43,742 |
| Poverty rate B17001 | 11.2% | 7.3% | 10.7% |
| Unemployment rate B23025 | 4.2% | 3.1% | 3.8% |
| Civilian labor force B23025 | 42,094 | 175,357 | 719,683 |
| Mean commute (minutes) B08013 | 19.4 | 23.2 | 24.6 |
| Bachelor's degree or higher B15003 | 59.7% | 53.0% | 36.2% |
| Housing units B25001 | 36,559 | 153,286 | 751,876 |
| Owner-occupied B25003 | 46.9% | 69.8% | 74.3% |
| Renters B25003 | 53.1% | 30.2% | 25.7% |
| Median home value B25077 | $489,600 | $451,200 | $296,600 |
| Median gross rent B25064 | $1,577 | $1,589 | $1,139 |
| White, not Hispanic B03002 | 77.5% | 85.6% | 89.9% |
| Black B03002 | 9.1% | 3.4% | 1.8% |
| Hispanic or Latino B03002 | 3.1% | 2.8% | 2.2% |
| Asian B03002 | 3.9% | 2.2% | 1.1% |
| American Indian and Alaska Native B03002 | 0.1% | 0.1% | 0.3% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Portland, ME.
Comments